Non-growing follicle density is increased following adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary | Zendy

Marie Mclaughlin | Zendy; Tom Kelsey | Zendy; William H. Wallace | Zendy; Richard A. Anderson | Zendy; Evelyn E. Telfer | Zendy

Open Access

Non-growing follicle density is increased following adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary

Author(s) -

Marie Mclaughlin,

Tom Kelsey,

William H. Wallace,

Richard A. Anderson,

Evelyn E. Telfer

Publication year - 2016

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dew260

Subject(s) - dacarbazine , abvd , vincristine , vinblastine , bleomycin , chemotherapy , prednisone , medicine , etoposide , doxorubicin , ovary , oncology , cyclophosphamide , cancer research

Do the chemotherapeutic regimens of ABVD (adriamycin, bleomycin, vinblastine and dacarbazine) or OEPA-COPDAC (combined vincristine, etoposide, prednisone, doxorubicin (OEPA) and cyclophosphamide, vincristine, prednisone, dacarbazine (COPDAC)) used to treat Hodgkin lymphoma (HL), affect the density, morphology and in vitro developmental potential of human ovarian follicles?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research